- Trump’s Feud With Federal Reserve Is Rooted in Presidential History (New York Times)
- Animal Spirits back in Biotech? AbbVie to buy Botox-maker Allergan in $63 billion deal (Reuters)
- China, U.S. trade officials talk ahead of Trump-Xi meeting (Reuters)
- Lennar’s stock surges after big profit, revenue beats (MarketWatch)
- Bristol-Myers’ Celgene Deal Can Still Be a Winner (Wall Street Journal)
- The Goldman Sachs Trump Chart That Should Scare Democrats Right Now (Barron’s)
- Micron Reports Earnings Today. Here’s What to Expect. (Barron’s)
- Trump Signs Executive Order Compelling Disclosure of Prices in Health Care (Wall Street Journal)
- Investors Are Glum, Even With Stocks at All-Time Highs (Wall Street Journal)
- U.S. Oil Exports Rising Amid Middle Eastern Turmoil (Wall Street Journal)